Evaluation of the Biomechanics of Crowding and the Energetic Cost of Endurance Runners Unilateral Transtibial Amputees. (BLADENDURUN)

Evaluation of the Biomechanics of Crowding and the Energetic Cost of Endurance Runners Unilateral Transtibial Amputees According to the Stiffness of the Race-specific Prothesis.

Transtibial amputation accounts for 3,700 cases per year in France. Athletes can use sport blades made of carbon plate for improved energy restitution.

Sports blades are adjusted according to the manufacturer's recommendations and the subjective experience of the ortho-prosthetist and patient. These adjustments are designed to optimize performance and comfort while reducing the risk of injury. This risk is all the greater when asymmetries between the healthy and affected limbs are large, exposing the healthy limb to large and repeated reaction forces.

Study Overview

Detailed Description

Furthermore, one of the performance criteria for long-distance running is energy cost. While a reduction in this parameter has been observed in bilateral amputees, heterogeneous data are reported in unilateral amputees, depending on the level of expertise and sports blade settings.

While studies have investigated the effects of running with a prosthesis under conditions representative of track running, few data are available on sports blades designed for long-distance running.

It therefore seems important to be able to objectively assess the effects of a change in the stiffness of the sports blade on the energetics and biomechanics of running, in order to optimize practice and prevent associated traumas.

Secondly, investigators believe it is important to verify that the biomechanical results obtained in the laboratory are applicable in the field, both on the road and on the unstable terrain encountered by trail runners.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Saint-Étienne, France, 42055
        • Recruiting
        • Centre Hospitalier Universitaire
        • Contact:
        • Principal Investigator:
          • David HUPIN, MD-PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female,
  • Weighing less than 110 kg, in accordance with C-blade recommendations,
  • Subjects who have undergone a unilateral transtibial amputation,
  • Have been running with a sports blade for at least 3 months, over several sessions of at least 3 kilometers.
  • Subjects who have signed a written consent form,
  • Subjects affiliated or entitled to a social security scheme.

Exclusion Criteria:

  • Subjects whose amputation is due to complications related to diabetes or atherosclerosis.
  • Subjects with chronic or central neurological pathologies
  • Subjects with cardiovascular disorders
  • Subjects with alcohol or drug dependency.
  • Pregnant or breast-feeding women
  • Subjects under court protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual blade stiffness
Data collection on a blade with usual stiffness during a run at comfort speed according to slope (flat, uphill +10% and downhill -10% on treadmill) and type of terrain (road, path).
5-minute warm-up run on treadmill at a freely chosen speed
4-minute run on a treadmill with a flat incline.
4-minute run on treadmill with a 10% gradient
1 min running test on an instrumented treadmill (Gaitway, H/P/Cosmos, Nußdorf, Germany) at comfort speed.
100-metre outdoor run at a comfort speed
Active Comparator: Less stiff blade
Data collection on a less stiff blade during a run at comfort speed according to slope (flat, uphill +10% and downhill -10% on treadmill) and type of terrain (road, path).
5-minute warm-up run on treadmill at a freely chosen speed
4-minute run on a treadmill with a flat incline.
4-minute run on treadmill with a 10% gradient
1 min running test on an instrumented treadmill (Gaitway, H/P/Cosmos, Nußdorf, Germany) at comfort speed.
100-metre outdoor run at a comfort speed
Active Comparator: Stiffer blade
Data collection on a stiffer blade during a run at comfort speed according to slope (flat, uphill +10% and downhill -10% on treadmill) and type of terrain (road, path).
5-minute warm-up run on treadmill at a freely chosen speed
4-minute run on a treadmill with a flat incline.
4-minute run on treadmill with a 10% gradient
1 min running test on an instrumented treadmill (Gaitway, H/P/Cosmos, Nußdorf, Germany) at comfort speed.
100-metre outdoor run at a comfort speed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen consumption measurement
Time Frame: Day 1
4-minute flat run on a treadmill at comfort speed
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen consumption measurement
Time Frame: Day 1
4-minute up hill run (+10%), on a treadmill at comfort speed
Day 1
Kinematic analysis
Time Frame: Day 1
Slope-dependent kinematic analysis by measuring joint angles (in degrees), moments (Nm) and net joint forces at ankle, knee and hip (in Nm/Kg), ground reaction forces (in N/Kg) during a 1-minute run on different slopes (downhill -10%, flat, uphill +10%).
Day 1
Cadence of running (in steps per minutes)
Time Frame: Day 1
Cadence of running according to slope (downhill -10%, flat, uphill +10%) and terrain, measured during a 1-minute run on a carpet
Day 1
Stride length (in meters) of running
Time Frame: Day 1
Stride length of running according to slope (downhill -10%, flat, uphill +10%) and terrain, measured during a 1-minute run on a carpet
Day 1
Cadence (in steps per minute) of running
Time Frame: Day 2
Cadence of running according to gradient (downhill -10%, flat, uphill +10%) and type of terrain, measured during a 100-metre run on roads and paths.
Day 2
Stride length (in metres) of running
Time Frame: Day 2
Stride length (in metres)of running according to gradient (downhill -10%, flat, uphill +10%) and type of terrain, measured during a 100-metre run on roads and paths.
Day 2
Leg muscle activity (mV)
Time Frame: Day 1, 2
Recording of leg muscle activity under all conditions using surface electromyographic recordings (Trigno wireless electromyogram (EMG) electrodes (Delsys, Natick, USA) made on the vastus lateralis, rectus femoris and gluteus medius muscles (Root Mean Square (RMS).
Day 1, 2
Subjective sensation recording
Time Frame: Day 1, 2

Recording of the subjective sensation of perceived exertion at the end of each condition using a Borg scale ranging from 0 to 10.

0 = It is very very easy 10= so hard that I have to stop

Day 1, 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David HUPIN, MD-PhD, Chu Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 23, 2025

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

February 7, 2025

First Submitted That Met QC Criteria

April 25, 2025

First Posted (Actual)

April 29, 2025

Study Record Updates

Last Update Posted (Actual)

August 5, 2025

Last Update Submitted That Met QC Criteria

August 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24CH148
  • 2024-A01795-42 (Other Identifier: ID RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe